Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 CRISPR and Cas gene industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product & services trends
2.1.4 Application trends
2.1.5 End-use trends
Chapter 3 CRISPR and Cas Gene Industry Insights
3.1 Industry segmentation
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing need for novel therapeutics
3.2.1.2 Rising demand for gene editing
3.2.1.3 Rising incidence of cancer
3.2.2 Industry pitfalls & challenges
3.2.2.1 Off target effects of crsipr technology
3.2.2.2 High cost factor, intellectual property disputes
3.3 Growth potential analysis
3.3.1 By product & services
3.3.2 By application
3.3.3 By end-use
3.4 COVID- 19 impact analysis
3.5 Regulatory landscape
3.6 Pipeline analysis
3.7 Porter's analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard
Chapter 5 CRISPR and Cas Gene Market Size and Forecast, By Product & Services (USD Million)
5.1 Key trends, by products & services
5.2 Product
5.2.1 Kits & Enzymes
5.2.1.1 Vector-based Cas
5.2.1.2 DNA-free Cas
5.2.2 Libraries
5.2.3 Design Tool
5.2.4 Antibodies
5.2.5 Other Products
5.3 Services
5.3.1 Cell Line Engineering
5.3.2 gRNA Design
5.3.3 Microbial Gene Editing
5.3.4 DNA Synthesis
5.3.5 Screening
Chapter 6 CRISPR and Cas Gene Market Size and Forecast, By Application (USD Million)
6.1 Key trends, by application
6.2 Genome Engineering
6.3 Disease Model Studies
6.4 Functional Genomics
6.5 Epigenetics
6.6 Other Applications
Chapter 7 CRISPR and Cas Gene Market Size and Forecast, By End-use (USD Million)
7.1 Key trends, by end-use
7.2 Biotechnology & Pharmaceutical Companies
7.3 Academics & Government Research Institutes
7.4 Contract Research Organizations (CROs)
Chapter 8 CRISPR and Cas Gene Market Size and Forecast, By Region (USD Million)
8.1 Key trends, by region
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Mexico
8.5.3 Rest of Latin America
8.6 Middle East & Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 Rest of Middle East & Africa
Chapter 9 Company Profiles
9.1 AstraZeneca plc
9.2 Addgene
9.3 Cellectis
9.4 CRISPR Therapeutics
9.5 Editas Medicine, Inc.
9.6 Thermo Fisher Scientific, Inc.
.9.7. F. Hoffmann-La Roche Ltd.
9.8 Horizon Discovery Group plc
9.9 Editas Medicine, Inc.
9.10 Intellia Therapeutics, Inc.
